speb/financial-data huggingface dataset:
HBP.TO balance_sheet (annual, 2022-07-31) — Other Current Liabilities: -1000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Other Equity Interest: 10335000.00
HBP.TO income_statement (annual, 2022-07-31) — Other Gand A: 901000.00
HBP.TO income_statement (annual, 2022-07-31) — Other Income Expense: -510000.00
HBP.TO cash_flow (annual, 2022-07-31) — Other Non Cash Items: -1000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Other Non Current Assets: 1000.00
HBP.TO income_statement (annual, 2022-07-31) — Other Non Operating Income Expenses: -501000.00
HBP.TO income_statement (annual, 2022-07-31) — Other Operating Expenses: 901000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Other Properties: 1356000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Other Receivables: 76000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Payables: 599000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Payables And Accrued Expenses: 944000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Prepaid Assets: 164000.00
HBP.TO income_statement (annual, 2022-07-31) — Pretax Income: -6564000.00
HBP.TO cash_flow (annual, 2022-07-31) — Proceeds From Stock Option Exercised: 3211000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Properties: 0.00
HBP.TO cash_flow (annual, 2022-07-31) — Purchase Of PPE: 0.00
HBP.TO balance_sheet (annual, 2022-07-31) — Receivables: 279000.00
HBP.TO income_statement (annual, 2022-07-31) — Reconciled Depreciation: 12000.00
HBP.TO cash_flow (annual, 2022-07-31) — Repayment Of Debt: 0.00
HBP.TO income_statement (annual, 2022-07-31) — Research And Development: 4544000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Retained Earnings: -195117000.00
HBP.TO income_statement (annual, 2022-07-31) — Salaries And Wages: 595000.00
HBP.TO cash_flow (annual, 2022-07-31) — Sale Of Business: 0.00
HBP.TO cash_flow (annual, 2022-07-31) — Sale Of PPE: 0.00
HBP.TO income_statement (annual, 2022-07-31) — Selling General And Administration: 1496000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Share Issued: 34358950.00
HBP.TO cash_flow (annual, 2022-07-31) — Short Term Debt Payments: 0.00
HBP.TO income_statement (annual, 2022-07-31) — Special Income Charges: 0.00
HBP.TO cash_flow (annual, 2022-07-31) — Stock Based Compensation: 425000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Stockholders Equity: 319000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Tangible Book Value: 319000.00
HBP.TO income_statement (annual, 2022-07-31) — Tax Effect Of Unusual Items: -2327.40
HBP.TO income_statement (annual, 2022-07-31) — Tax Rate For Calcs: 0.26
HBP.TO balance_sheet (annual, 2022-07-31) — Taxes Receivable: 203000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Total Assets: 3731000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Total Capitalization: 319000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Total Debt: 2468000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Total Equity Gross Minority Interest: 319000.00
HBP.TO income_statement (annual, 2022-07-31) — Total Expenses: 6040000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Total Liabilities Net Minority Interest: 3412000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Total Non Current Assets: 35000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
HBP.TO income_statement (annual, 2022-07-31) — Total Unusual Items: -9000.00
HBP.TO income_statement (annual, 2022-07-31) — Total Unusual Items Excluding Goodwill: -9000.00
HBP.TO cash_flow (annual, 2022-07-31) — Unrealized Gain Loss On Investment Securities: 501000.00
HBP.TO balance_sheet (annual, 2022-07-31) — Working Capital: 283000.00
HBP.TO income_statement (annual, 2023-07-31) — +Operating Expense: 6326000.00
HBP.TO income_statement (annual, 2023-07-31) — +Total Revenue: 0.00
HBP.TO balance_sheet (annual, 2023-07-31) — Accounts Payable: 493000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Accumulated Depreciation: -1791000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Additional Paid In Capital: 44137000.00
HBP.TO income_statement (annual, 2023-07-31) — Basic Average Shares: 38645738.00
HBP.TO income_statement (annual, 2023-07-31) — Basic EPS: -0.16
HBP.TO cash_flow (annual, 2023-07-31) — Beginning Cash Position: 3252000.00
HBP.TO cash_flow (annual, 2023-07-31) — Capital Expenditure: -10000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Capital Stock: 152068000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Cash And Cash Equivalents: 808000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Cash Cash Equivalents And Short Term Investments: 808000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Cash Financial: 808000.00
HBP.TO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Financing Activities: 3087000.00
HBP.TO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Investing Activities: -5000.00
HBP.TO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Operating Activities: -5526000.00
HBP.TO cash_flow (annual, 2023-07-31) — Change In Account Payable: -106000.00
HBP.TO cash_flow (annual, 2023-07-31) — Change In Accrued Expense: 38000.00
HBP.TO cash_flow (annual, 2023-07-31) — Change In Payable: -106000.00
HBP.TO cash_flow (annual, 2023-07-31) — Change In Payables And Accrued Expense: -69000.00
HBP.TO cash_flow (annual, 2023-07-31) — Change In Prepaid Assets: 37000.00
HBP.TO cash_flow (annual, 2023-07-31) — Change In Receivables: 217000.00
HBP.TO cash_flow (annual, 2023-07-31) — Change In Working Capital: 185000.00
HBP.TO cash_flow (annual, 2023-07-31) — Changes In Account Receivables: 217000.00
HBP.TO cash_flow (annual, 2023-07-31) — Changes In Cash: -2444000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Common Stock: 152068000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Common Stock Equity: -845000.00
HBP.TO cash_flow (annual, 2023-07-31) — Common Stock Issuance: 4151000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Current Accrued Expenses: 383000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Current Assets: 996000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Current Liabilities: 1874000.00
HBP.TO cash_flow (annual, 2023-07-31) — Depreciation: 13000.00
HBP.TO cash_flow (annual, 2023-07-31) — Depreciation Amortization Depletion: 13000.00
HBP.TO cash_flow (annual, 2023-07-31) — Depreciation And Amortization: 13000.00
HBP.TO income_statement (annual, 2023-07-31) — Diluted Average Shares: 38645738.00
HBP.TO income_statement (annual, 2023-07-31) — Diluted EPS: -0.16
HBP.TO income_statement (annual, 2023-07-31) — Diluted NI Availto Com Stockholders: -6290000.00
HBP.TO income_statement (annual, 2023-07-31) — EBIT: -6276000.00
HBP.TO income_statement (annual, 2023-07-31) — EBITDA: -6263000.00
HBP.TO cash_flow (annual, 2023-07-31) — Effect Of Exchange Rate Changes: 0.00
HBP.TO cash_flow (annual, 2023-07-31) — End Cash Position: 808000.00
HBP.TO cash_flow (annual, 2023-07-31) — Financing Cash Flow: 3087000.00
HBP.TO cash_flow (annual, 2023-07-31) — Free Cash Flow: -5536000.00
HBP.TO cash_flow (annual, 2023-07-31) — Gain Loss On Sale Of PPE: -5000.00
HBP.TO income_statement (annual, 2023-07-31) — Gain On Sale Of Ppe: 5000.00
HBP.TO income_statement (annual, 2023-07-31) — Gain On Sale Of Security: -2000.00
HBP.TO income_statement (annual, 2023-07-31) — General And Administrative Expense: 1045000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Gross PPE: 1824000.00
HBP.TO income_statement (annual, 2023-07-31) — Interest Expense: 14000.00
HBP.TO income_statement (annual, 2023-07-31) — Interest Expense Non Operating: 14000.00
HBP.TO income_statement (annual, 2023-07-31) — Interest Income: 47000.00
HBP.TO income_statement (annual, 2023-07-31) — Interest Income Non Operating: 47000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Invested Capital: -845000.00
HBP.TO cash_flow (annual, 2023-07-31) — Investing Cash Flow: -5000.00
HBP.TO cash_flow (annual, 2023-07-31) — Issuance Of Capital Stock: 4151000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Leases: 359000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Machinery Furniture Equipment: 109000.00
HBP.TO cash_flow (annual, 2023-07-31) — Net Common Stock Issuance: 4151000.00
HBP.TO cash_flow (annual, 2023-07-31) — Net Foreign Currency Exchange Gain Loss: 2000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Income: -6290000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Income Common Stockholders: -6290000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Income Continuous Operations: -6290000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Income From Continuing And Discontinued Operation: -6290000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Income From Continuing Operation Net Minority Interest: -6290000.00
HBP.TO cash_flow (annual, 2023-07-31) — Net Income From Continuing Operations: -6290000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Income Including Noncontrolling Interests: -6290000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Interest Income: 33000.00
HBP.TO cash_flow (annual, 2023-07-31) — Net Issuance Payments Of Debt: -2062000.00
HBP.TO income_statement (annual, 2023-07-31) — Net Non Operating Interest Income Expense: 33000.00
HBP.TO cash_flow (annual, 2023-07-31) — Net Other Financing Charges: 998000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Net PPE: 33000.00
HBP.TO cash_flow (annual, 2023-07-31) — Net PPE Purchase And Sale: -5000.00
HBP.TO cash_flow (annual, 2023-07-31) — Net Short Term Debt Issuance: -2062000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Net Tangible Assets: -845000.00
HBP.TO income_statement (annual, 2023-07-31) — Normalized EBITDA: -6266000.00
HBP.TO income_statement (annual, 2023-07-31) — Normalized Income: -6292220.00
HBP.TO cash_flow (annual, 2023-07-31) — Operating Cash Flow: -5526000.00
HBP.TO cash_flow (annual, 2023-07-31) — Operating Gains Losses: -3000.00
HBP.TO income_statement (annual, 2023-07-31) — Operating Income: -6326000.00
HBP.TO income_statement (annual, 2023-07-31) — Operating Revenue: 0.00
HBP.TO balance_sheet (annual, 2023-07-31) — Ordinary Shares Number: 40003771.00
HBP.TO balance_sheet (annual, 2023-07-31) — Other Current Liabilities: 998000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Other Equity Interest: 4357000.00
HBP.TO income_statement (annual, 2023-07-31) — Other Gand A: 746000.00
HBP.TO income_statement (annual, 2023-07-31) — Other Income Expense: 3000.00
HBP.TO income_statement (annual, 2023-07-31) — Other Operating Expenses: 746000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Other Properties: 1356000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Other Receivables: 15000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Payables: 493000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Payables And Accrued Expenses: 876000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Prepaid Assets: 126000.00
HBP.TO income_statement (annual, 2023-07-31) — Pretax Income: -6290000.00
HBP.TO cash_flow (annual, 2023-07-31) — Proceeds From Stock Option Exercised: 0.00
HBP.TO balance_sheet (annual, 2023-07-31) — Properties: 0.00
HBP.TO cash_flow (annual, 2023-07-31) — Purchase Of PPE: -10000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Receivables: 62000.00
HBP.TO income_statement (annual, 2023-07-31) — Reconciled Depreciation: 13000.00
HBP.TO cash_flow (annual, 2023-07-31) — Repayment Of Debt: -2062000.00
HBP.TO income_statement (annual, 2023-07-31) — Research And Development: 5281000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Retained Earnings: -201407000.00
HBP.TO income_statement (annual, 2023-07-31) — Salaries And Wages: 299000.00
HBP.TO cash_flow (annual, 2023-07-31) — Sale Of PPE: 5000.00
HBP.TO income_statement (annual, 2023-07-31) — Selling General And Administration: 1045000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Share Issued: 40003771.00
HBP.TO cash_flow (annual, 2023-07-31) — Short Term Debt Payments: -2062000.00
HBP.TO income_statement (annual, 2023-07-31) — Special Income Charges: 5000.00
HBP.TO cash_flow (annual, 2023-07-31) — Stock Based Compensation: 569000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Stockholders Equity: -845000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Tangible Book Value: -845000.00
HBP.TO income_statement (annual, 2023-07-31) — Tax Effect Of Unusual Items: 780.00
HBP.TO income_statement (annual, 2023-07-31) — Tax Rate For Calcs: 0.26
HBP.TO balance_sheet (annual, 2023-07-31) — Taxes Receivable: 47000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Total Assets: 1029000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Total Capitalization: -845000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Total Equity Gross Minority Interest: -845000.00
HBP.TO income_statement (annual, 2023-07-31) — Total Expenses: 6326000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Total Liabilities Net Minority Interest: 1874000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Total Non Current Assets: 33000.00
HBP.TO balance_sheet (annual, 2023-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
HBP.TO income_statement (annual, 2023-07-31) — Total Unusual Items: 3000.00
HBP.TO income_statement (annual, 2023-07-31) — Total Unusual Items Excluding Goodwill: 3000.00
HBP.TO cash_flow (annual, 2023-07-31) — Unrealized Gain Loss On Investment Securities: 0.00
HBP.TO balance_sheet (annual, 2023-07-31) — Working Capital: -878000.00
HBP.TO income_statement (annual, 2024-07-31) — +Operating Expense: 9239000.00
HBP.TO income_statement (annual, 2024-07-31) — +Total Revenue: 0.00
HBP.TO balance_sheet (annual, 2024-07-31) — Accounts Payable: 855000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Accumulated Depreciation: -1805000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Additional Paid In Capital: 47360000.00
HBP.TO income_statement (annual, 2024-07-31) — Basic Average Shares: 44485915.00
HBP.TO income_statement (annual, 2024-07-31) — Basic EPS: -0.21
HBP.TO cash_flow (annual, 2024-07-31) — Beginning Cash Position: 808000.00
HBP.TO cash_flow (annual, 2024-07-31) — Capital Expenditure: -14000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Capital Stock: 158572000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Cash And Cash Equivalents: 1081000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Cash Cash Equivalents And Short Term Investments: 1081000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Cash Financial: 1081000.00
HBP.TO cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Financing Activities: 5506000.00
HBP.TO cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Investing Activities: -14000.00
HBP.TO cash_flow (annual, 2024-07-31) — Cash Flow From Continuing Operating Activities: -5219000.00
HBP.TO cash_flow (annual, 2024-07-31) — Change In Payables And Accrued Expense: 671000.00
HBP.TO cash_flow (annual, 2024-07-31) — Change In Prepaid Assets: -194000.00
HBP.TO cash_flow (annual, 2024-07-31) — Change In Receivables: 8000.00
HBP.TO cash_flow (annual, 2024-07-31) — Change In Working Capital: 485000.00
HBP.TO cash_flow (annual, 2024-07-31) — Changes In Account Receivables: 8000.00
HBP.TO cash_flow (annual, 2024-07-31) — Changes In Cash: 273000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Common Stock: 158572000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Common Stock Equity: -90000.00
HBP.TO cash_flow (annual, 2024-07-31) — Common Stock Issuance: 5506000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Current Accrued Expenses: 724000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Current Assets: 1456000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Current Liabilities: 1579000.00
HBP.TO cash_flow (annual, 2024-07-31) — Depreciation: 14000.00
HBP.TO cash_flow (annual, 2024-07-31) — Depreciation Amortization Depletion: 14000.00
HBP.TO cash_flow (annual, 2024-07-31) — Depreciation And Amortization: 14000.00
HBP.TO income_statement (annual, 2024-07-31) — Diluted Average Shares: 44485915.00
HBP.TO income_statement (annual, 2024-07-31) — Diluted EPS: -0.21
HBP.TO income_statement (annual, 2024-07-31) — Diluted NI Availto Com Stockholders: -9264000.00
HBP.TO income_statement (annual, 2024-07-31) — EBIT: -9257000.00
HBP.TO income_statement (annual, 2024-07-31) — EBITDA: -9243000.00
HBP.TO cash_flow (annual, 2024-07-31) — End Cash Position: 1081000.00
HBP.TO cash_flow (annual, 2024-07-31) — Financing Cash Flow: 5506000.00
HBP.TO cash_flow (annual, 2024-07-31) — Free Cash Flow: -5233000.00
HBP.TO cash_flow (annual, 2024-07-31) — Gain Loss On Sale Of PPE: 0.00
HBP.TO income_statement (annual, 2024-07-31) — Gain On Sale Of Ppe: 0.00
HBP.TO income_statement (annual, 2024-07-31) — Gain On Sale Of Security: -49000.00
HBP.TO income_statement (annual, 2024-07-31) — General And Administrative Expense: 3262000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Gross PPE: 1838000.00
HBP.TO income_statement (annual, 2024-07-31) — Interest Expense: 7000.00
HBP.TO income_statement (annual, 2024-07-31) — Interest Expense Non Operating: 7000.00
HBP.TO income_statement (annual, 2024-07-31) — Interest Income: 31000.00
HBP.TO income_statement (annual, 2024-07-31) — Interest Income Non Operating: 31000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Invested Capital: -90000.00
HBP.TO cash_flow (annual, 2024-07-31) — Investing Cash Flow: -14000.00
HBP.TO cash_flow (annual, 2024-07-31) — Issuance Of Capital Stock: 5506000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Leases: 359000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Machinery Furniture Equipment: 111000.00
HBP.TO cash_flow (annual, 2024-07-31) — Net Common Stock Issuance: 5506000.00
HBP.TO cash_flow (annual, 2024-07-31) — Net Foreign Currency Exchange Gain Loss: 31000.00
HBP.TO income_statement (annual, 2024-07-31) — Net Income: -9264000.00
HBP.TO income_statement (annual, 2024-07-31) — Net Income Common Stockholders: -9264000.00
HBP.TO income_statement (annual, 2024-07-31) — Net Income Continuous Operations: -9264000.00
HBP.TO income_statement (annual, 2024-07-31) — Net Income From Continuing And Discontinued Operation: -9264000.00
HBP.TO income_statement (annual, 2024-07-31) — Net Income From Continuing Operation Net Minority Interest: -9264000.00
HBP.TO cash_flow (annual, 2024-07-31) — Net Income From Continuing Operations: -9264000.00
HBP.TO income_statement (annual, 2024-07-31) — Net Income Including Noncontrolling Interests: -9264000.00
HBP.TO income_statement (annual, 2024-07-31) — Net Interest Income: 24000.00
HBP.TO cash_flow (annual, 2024-07-31) — Net Issuance Payments Of Debt: 0.00
HBP.TO income_statement (annual, 2024-07-31) — Net Non Operating Interest Income Expense: 24000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Net PPE: 33000.00
HBP.TO cash_flow (annual, 2024-07-31) — Net PPE Purchase And Sale: -14000.00
HBP.TO cash_flow (annual, 2024-07-31) — Net Short Term Debt Issuance: 0.00
HBP.TO balance_sheet (annual, 2024-07-31) — Net Tangible Assets: -90000.00
HBP.TO income_statement (annual, 2024-07-31) — Normalized EBITDA: -9194000.00
HBP.TO income_statement (annual, 2024-07-31) — Normalized Income: -9227740.00
HBP.TO cash_flow (annual, 2024-07-31) — Operating Cash Flow: -5219000.00
HBP.TO cash_flow (annual, 2024-07-31) — Operating Gains Losses: 31000.00
HBP.TO income_statement (annual, 2024-07-31) — Operating Income: -9239000.00
HBP.TO income_statement (annual, 2024-07-31) — Operating Revenue: 0.00
HBP.TO balance_sheet (annual, 2024-07-31) — Ordinary Shares Number: 49021536.00
HBP.TO balance_sheet (annual, 2024-07-31) — Other Equity Interest: 4649000.00
HBP.TO income_statement (annual, 2024-07-31) — Other Gand A: 687000.00
HBP.TO income_statement (annual, 2024-07-31) — Other Income Expense: -49000.00
HBP.TO income_statement (annual, 2024-07-31) — Other Operating Expenses: 687000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Other Properties: 1368000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Other Receivables: 15000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Payables: 855000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Payables And Accrued Expenses: 1579000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Prepaid Assets: 321000.00
HBP.TO income_statement (annual, 2024-07-31) — Pretax Income: -9264000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Properties: 0.00
HBP.TO cash_flow (annual, 2024-07-31) — Purchase Of PPE: -14000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Receivables: 54000.00
HBP.TO income_statement (annual, 2024-07-31) — Reconciled Depreciation: 14000.00
HBP.TO cash_flow (annual, 2024-07-31) — Repayment Of Debt: 0.00
HBP.TO income_statement (annual, 2024-07-31) — Research And Development: 5977000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Retained Earnings: -210671000.00
HBP.TO income_statement (annual, 2024-07-31) — Salaries And Wages: 2575000.00
HBP.TO cash_flow (annual, 2024-07-31) — Sale Of PPE: 0.00
HBP.TO income_statement (annual, 2024-07-31) — Selling General And Administration: 3262000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Share Issued: 49021536.00
HBP.TO cash_flow (annual, 2024-07-31) — Short Term Debt Payments: 0.00
HBP.TO income_statement (annual, 2024-07-31) — Special Income Charges: 0.00
HBP.TO cash_flow (annual, 2024-07-31) — Stock Based Compensation: 3515000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Stockholders Equity: -90000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Tangible Book Value: -90000.00
HBP.TO income_statement (annual, 2024-07-31) — Tax Effect Of Unusual Items: -12740.00
HBP.TO income_statement (annual, 2024-07-31) — Tax Rate For Calcs: 0.26
HBP.TO balance_sheet (annual, 2024-07-31) — Taxes Receivable: 39000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Total Assets: 1489000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Total Capitalization: -90000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Total Equity Gross Minority Interest: -90000.00
HBP.TO income_statement (annual, 2024-07-31) — Total Expenses: 9239000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Total Liabilities Net Minority Interest: 1579000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Total Non Current Assets: 33000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
HBP.TO income_statement (annual, 2024-07-31) — Total Unusual Items: -49000.00
HBP.TO income_statement (annual, 2024-07-31) — Total Unusual Items Excluding Goodwill: -49000.00
HBP.TO balance_sheet (annual, 2024-07-31) — Working Capital: -123000.00
HBP.TO income_statement (quarterly, 2024-10-31) — +Operating Expense: 1594000.00
HBP.TO income_statement (quarterly, 2024-10-31) — +Total Revenue: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Accounts Payable: 988000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Accumulated Depreciation: -1325000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Additional Paid In Capital: 46828000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Basic Average Shares: 49021536.00
HBP.TO income_statement (quarterly, 2024-10-31) — Basic EPS: -0.03
HBP.TO cash_flow (quarterly, 2024-10-31) — Beginning Cash Position: 1081000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Capital Stock: 158572000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Cash And Cash Equivalents: 228000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Cash Cash Equivalents And Short Term Investments: 228000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Cash Financial: 228000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Financing Activities: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Investing Activities: 8000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Cash Flow From Continuing Operating Activities: -861000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Change In Other Current Liabilities: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Change In Payables And Accrued Expense: 476000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Change In Prepaid Assets: 181000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Change In Receivables: 18000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Change In Working Capital: 675000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Changes In Account Receivables: 18000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Changes In Cash: -853000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Common Stock: 158572000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Common Stock Equity: -1364000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Common Stock Issuance: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Current Accrued Expenses: 790000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Current Assets: 404000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Current Liabilities: 1778000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Deferred Income Tax: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Deferred Tax: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Depreciation: 4000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Depreciation Amortization Depletion: 4000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Depreciation And Amortization: 4000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Diluted Average Shares: 49021536.00
HBP.TO income_statement (quarterly, 2024-10-31) — Diluted EPS: -0.03
HBP.TO income_statement (quarterly, 2024-10-31) — Diluted NI Availto Com Stockholders: -1336000.00
HBP.TO income_statement (quarterly, 2024-10-31) — EBIT: -1335000.00
HBP.TO income_statement (quarterly, 2024-10-31) — EBITDA: -1331000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Effect Of Exchange Rate Changes: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — End Cash Position: 228000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Financing Cash Flow: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Free Cash Flow: -861000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Gain Loss On Sale Of PPE: -6000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Gain On Sale Of Ppe: 6000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Gain On Sale Of Security: -22000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Gross PPE: 1335000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Interest Expense: 1000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Interest Expense Non Operating: 1000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Interest Income: 7000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Interest Income Non Operating: 7000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Interest Paid Supplemental Data: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Invested Capital: -1364000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Investing Cash Flow: 8000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Issuance Of Capital Stock: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Leases: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Machinery Furniture Equipment: 104000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Net Common Stock Issuance: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Net Foreign Currency Exchange Gain Loss: 8000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Income: -1336000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Income Common Stockholders: -1336000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Income Continuous Operations: -1336000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Income From Continuing And Discontinued Operation: -1336000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Income From Continuing Operation Net Minority Interest: -1336000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Net Income From Continuing Operations: -1336000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Income Including Noncontrolling Interests: -1336000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Interest Income: 6000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Net Non Operating Interest Income Expense: 6000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Net PPE: 10000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Net PPE Purchase And Sale: 8000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Net Tangible Assets: -1364000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Normalized EBITDA: -1315000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Normalized Income: -1320000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Operating Cash Flow: -861000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Operating Gains Losses: 2000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Operating Income: -1594000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Operating Revenue: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Ordinary Shares Number: 49021536.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Other Equity Interest: 5243000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Other Income Expense: 252000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Other Non Cash Items: -268000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Other Non Operating Income Expenses: 268000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Other Operating Expenses: 245000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Other Properties: 1231000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Other Receivables: 155000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Other Special Charges: -268000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Payables: 988000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Payables And Accrued Expenses: 1778000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Pretax Income: -1336000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Properties: 0.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Purchase Of PPE: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Receivables: 176000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Reconciled Depreciation: 4000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Research And Development: 1321000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Retained Earnings: -212007000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Salaries And Wages: 28000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Sale Of PPE: 8000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Share Issued: 49021536.00
HBP.TO income_statement (quarterly, 2024-10-31) — Special Income Charges: 6000.00
HBP.TO cash_flow (quarterly, 2024-10-31) — Stock Based Compensation: 62000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Stockholders Equity: -1364000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Tangible Book Value: -1364000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Tax Effect Of Unusual Items: 0.00
HBP.TO income_statement (quarterly, 2024-10-31) — Tax Rate For Calcs: 0.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Taxes Receivable: 21000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Total Assets: 414000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Total Capitalization: -1364000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Total Equity Gross Minority Interest: -1364000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Total Expenses: 1594000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Total Liabilities Net Minority Interest: 1778000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Total Non Current Assets: 10000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Total Non Current Liabilities Net Minority Interest: 0.00
HBP.TO income_statement (quarterly, 2024-10-31) — Total Unusual Items: -16000.00
HBP.TO income_statement (quarterly, 2024-10-31) — Total Unusual Items Excluding Goodwill: -16000.00
HBP.TO balance_sheet (quarterly, 2024-10-31) — Working Capital: -1374000.00
HBP.TO income_statement (quarterly, 2025-01-31) — +Operating Expense: 1292000.00
HBP.TO income_statement (quarterly, 2025-01-31) — +Total Revenue: 0.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Accounts Payable: 1440000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Accumulated Depreciation: -1232000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Additional Paid In Capital: 47333000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Basic Average Shares: 50065014.00
HBP.TO income_statement (quarterly, 2025-01-31) — Basic EPS: -0.03
HBP.TO cash_flow (quarterly, 2025-01-31) — Beginning Cash Position: 228000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Capital Stock: 161257000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Cash And Cash Equivalents: 1996000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Cash Cash Equivalents And Short Term Investments: 1996000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Cash Financial: 1996000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Financing Activities: 2699000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Investing Activities: 9000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Cash Flow From Continuing Operating Activities: -940000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Change In Other Current Liabilities: 0.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Change In Payables And Accrued Expense: 362000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Change In Prepaid Assets: -62000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Change In Receivables: 2000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Change In Working Capital: 302000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Changes In Account Receivables: 2000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Changes In Cash: 1768000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Common Stock: 161257000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Common Stock Equity: -19000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Common Stock Issuance: 2699000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Current Accrued Expenses: 821000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Current Assets: 2232000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Current Liabilities: 2261000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Deferred Income Tax: 0.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Deferred Tax: 0.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Depreciation: 2000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Depreciation Amortization Depletion: 2000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Depreciation And Amortization: 2000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Diluted Average Shares: 50065014.00
HBP.TO income_statement (quarterly, 2025-01-31) — Diluted EPS: -0.03
HBP.TO income_statement (quarterly, 2025-01-31) — Diluted NI Availto Com Stockholders: -1375000.00
HBP.TO income_statement (quarterly, 2025-01-31) — EBIT: -1372000.00
HBP.TO income_statement (quarterly, 2025-01-31) — EBITDA: -1370000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Effect Of Exchange Rate Changes: 0.00
HBP.TO cash_flow (quarterly, 2025-01-31) — End Cash Position: 1996000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Financing Cash Flow: 2699000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Free Cash Flow: -942000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Gain Loss On Sale Of PPE: -13000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Gain On Sale Of Ppe: 13000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Gain On Sale Of Security: -95000.00
HBP.TO income_statement (quarterly, 2025-01-31) — General And Administrative Expense: 444000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Gross PPE: 1242000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Interest Expense: 3000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Interest Expense Non Operating: 3000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Interest Income: 2000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 2000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Interest Paid Supplemental Data: 0.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Invested Capital: -19000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: 9000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Issuance Of Capital Stock: 2699000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Leases: 0.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 106000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: 2699000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Net Foreign Currency Exchange Gain Loss: 109000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Income: -1375000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: -1375000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: -1375000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -1375000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -1375000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: -1375000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: -1375000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Interest Income: -1000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -1000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Net PPE: 10000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: 9000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: -19000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Normalized EBITDA: -1288000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Normalized Income: -1293000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: -940000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 96000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Operating Income: -1292000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Operating Revenue: 0.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 53021536.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Other Equity Interest: 4773000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Other Gand A: 422000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Other Income Expense: -82000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 0.00
HBP.TO income_statement (quarterly, 2025-01-31) — Other Operating Expenses: 422000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Other Properties: 1136000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Other Receivables: 217000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Payables: 1440000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 2261000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Pretax Income: -1375000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Properties: 0.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -2000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Receivables: 236000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 2000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Research And Development: 848000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Retained Earnings: -213382000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Salaries And Wages: 22000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Sale Of PPE: 11000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Selling General And Administration: 444000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Share Issued: 53021536.00
HBP.TO income_statement (quarterly, 2025-01-31) — Special Income Charges: 13000.00
HBP.TO cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 35000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: -19000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: -19000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
HBP.TO income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Taxes Receivable: 19000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Total Assets: 2242000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Total Capitalization: -19000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: -19000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Total Expenses: 1292000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 2261000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 10000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 0.00
HBP.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items: -82000.00
HBP.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -82000.00
HBP.TO balance_sheet (quarterly, 2025-01-31) — Working Capital: -29000.00
HBP.TO income_statement (quarterly, 2025-04-30) — +Operating Expense: 1553000.00
HBP.TO income_statement (quarterly, 2025-04-30) — +Total Revenue: 0.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 1782000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -1234000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 48297000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Basic Average Shares: 53035581.00
HBP.TO income_statement (quarterly, 2025-04-30) — Basic EPS: -0.03
HBP.TO cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 1996000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Capital Stock: 161388000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 715000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 715000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Cash Financial: 715000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: 100000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: 0.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: -1381000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Change In Other Current Liabilities: 0.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 153000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -53000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Change In Receivables: 2000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 102000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: 2000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Changes In Cash: -1281000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Common Stock: 161388000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: -1390000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Common Stock Issuance: 100000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 617000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Current Assets: 1002000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 2399000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: 0.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Deferred Tax: 0.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Depreciation: 3000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 3000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 3000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 53035581.00
HBP.TO income_statement (quarterly, 2025-04-30) — Diluted EPS: -0.03
HBP.TO income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -1544000.00
HBP.TO income_statement (quarterly, 2025-04-30) — EBIT: -1530000.00
HBP.TO income_statement (quarterly, 2025-04-30) — EBITDA: -1527000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Effect Of Exchange Rate Changes: 0.00
HBP.TO cash_flow (quarterly, 2025-04-30) — End Cash Position: 715000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: 100000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Free Cash Flow: -1381000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Gain Loss On Sale Of PPE: 2000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Gain On Sale Of Ppe: -1000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Gain On Sale Of Security: 4000.00
HBP.TO income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 647000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Gross PPE: 1241000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Interest Expense: 14000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 14000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Interest Income: 20000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 20000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Invested Capital: -1390000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: 0.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Issuance Of Capital Stock: 100000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Leases: 0.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Machinery Furniture Equipment: 105000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: 100000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Net Foreign Currency Exchange Gain Loss: -4000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Income: -1544000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -1544000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -1544000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -1544000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -1544000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -1544000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -1544000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Interest Income: 6000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: 6000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Net PPE: 7000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: 0.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: -1390000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -1530000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Normalized Income: -1547000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: -1381000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: -2000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Operating Income: -1553000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Operating Revenue: 0.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 53146536.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Other Equity Interest: 3851000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Other Gand A: 542000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Other Income Expense: 3000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 0.00
HBP.TO income_statement (quarterly, 2025-04-30) — Other Operating Expenses: 541000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Other Properties: 1136000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Other Receivables: 270000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Payables: 1782000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 2399000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Pretax Income: -1544000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Properties: 0.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: 0.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Receivables: 287000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 3000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Research And Development: 906000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -214926000.00
HBP.TO income_statement (quarterly, 2025-04-30) — Salaries And Wages: 105000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Sale Of PPE: 0.00
HBP.TO income_statement (quarterly, 2025-04-30) — Selling General And Administration: 647000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Share Issued: 53146536.00
HBP.TO income_statement (quarterly, 2025-04-30) — Special Income Charges: -1000.00
HBP.TO cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 60000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: -1390000.00
HBP.TO balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: -1390000.00